A Novant Health breast surgeon led clinical trial research that supported the FDA approval of the only in vivo detection of residual breast cancer.

Katie Toussaint

Contributing Writer

Published June 19, 2024

Be Informed. Specialty Care Insights. Latest Advancements.

The latest thought leadership delivered straight to your inbox.

We offer a seamless referral process and are committed to ensuring your patients receive expert, compassionate care.